Corcept Therapeutics Incorporated

CORTRank #230 of 316

Reference Jun 30, 2026 close implied by Form 13F filings

Circulating market cap

$9.40B

Upper bound: lock-ups and restricted stock not reviewed yet.

Traditional market cap: $9.40B
Fully diluted value: $10.53B
Free float market cap: -
Gap to traditional: 0

Circulating supply108.10M / 108.10M

Free float
Locked team
Other restricted

Circulating: 108.10M · 100.0%
Free float: -
Locked team: n/r
Other restricted: n/r
Total outstanding: 108,098,397

Lock-ups and restricted stock for this company have not been reviewed yet. Only unlisted share classes are excluded, so circulating supply is an upper bound.

Supply breakdown

Shares as of Jul 22, 2026

Circulating100.0%108.10M shares

Category	Shares	%	Value	Status
Circulating	108.10M	100.0%	$9.40B	Estimated
Free float	-	-	-	Unavailable
Insider-held, unrestricted	-	-	-	Unavailable
Locked team funds	-	-	-	Unavailable
Other restricted (unlisted classes only)	-	-	-	Unavailable
Total outstanding	108.10M	100.0%	$9.40B	Verified
Ownership views (overlap the categories above, never added)
Institutional holdings (13F)	82.33M	76.2%	$7.16B	Estimated
Insider-held, all (Forms 3, 4, 5)	-	-	-	Unavailable

Institutional and insider holdings can include both tradable and locked shares, so they are shown for reference and never added to the total. Check: no class has more shares deducted than it has outstanding, and the review found no shares that may be counted twice: reconciles.

Valuation

Traditional$9.40B
Fully diluted$10.53B
Circulating$9.40B
Free float-
Locked team value$0
Other restricted value$0

Locked and restricted shares

Not reviewed yet.

Institutional holders

13F, quarter ended Jun 30, 2026

Holder	Shares	% of total
BlackRock, Inc.	12.43M	11.50%
INGALLS & SNYDER LLC	7.93M	7.34%
RENAISSANCE TECHNOLOGIES LLC	5.26M	4.87%
VANGUARD PORTFOLIO MANAGEMENT LLC	5.04M	4.67%
VANGUARD CAPITAL MANAGEMENT LLC	4.17M	3.86%
Parallel Advisors, LLC	3.96M	3.67%
FMR LLC	3.34M	3.09%
STATE STREET CORP	3.28M	3.03%
AQR CAPITAL MANAGEMENT LLC	2.58M	2.39%
GEODE CAPITAL MANAGEMENT, LLC	2.53M	2.34%

Sum of long share positions in Form 13F reports for the quarter. 13F covers managers with over $100M in US equities; some positions are reported by more than one filer.

Insiders

Forms 3, 4 and 5

Form 4 aggregation pending

Share classes

Class	Listing	Shares outstanding	As of
Common stock	CORT on Nasdaq	108,098,397	Jul 22, 2026

Notes and sources

CORCEPT THERAPEUTICS INC 10-Q for period ended 2026-06-30, Cover page (0001628280-26-050613)
SEC public float (non-affiliates): $6.11B as of Jun 30, 2025, from the 10-K cover. It is a dollar value at a past date, not circulating supply.